BPC-157 Injection Quick Facts Route Subcutaneous (under the skin, not into muscle) Standard Sites Abdomen, thigh, upper glute, back of deltoid Most Common Site Abdomen (consistent absorption, easy to see) Needle 27-31 gauge insulin syringe, 1/2 inch length Volume Small, typically 0.1-0.3 mL per injection Ships BPC-157 Is a Subcutaneous Injection Where to inject BPC-157: the abdomen, thigh, upper outer glute, or back of the arm
Diabetic peripheral neuropathy Peripheral nerve dysfunction occurs in about 50% of people with diabetes mellitus, and chronic neuropathic pain is present in about one-third of people with diabetic peripheral neuropathy (85)
Injections allow for direct absorption when dietary intake or oral supplementation may be insufficient
Glutathione Injections What Really Happens
GLP-1 agonists have already transformed the treatment landscape for diabetes and obesity, and their potential role in addiction medicine represents an exciting new frontier